← Browse by Condition
Medical Condition

chronic hepatitis d

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3
NCT07454837 Phase 2, Phase 3
Recruiting

Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide

Enrollment
120 pts
Location
Romania, United King...
Sponsor
Mirum Pharmaceuticals, Inc.
View Trial →